Shanghai ZJ Bio-Tech Co., Ltd (SHA:688317)

Market Cap	3.72B +19.2%
Revenue (ttm)	131.50M -36.4%
Net Income	-143.83M
EPS	-0.76
Shares Out	177.52M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,856,971
Average Volume	6,540,131
Open	21.10
Previous Close	21.04
Day's Range	20.93 - 21.18
52-Week Range	14.88 - 29.49
Beta	0.61
RSI	43.63
Earnings Date	Apr 24, 2026

About Shanghai ZJ Bio-Tech

Shanghai ZJ Bio-Tech Co., Ltd. engages in the research and development, production, and sale of molecular diagnostic reagents and instruments in China and internationally. It offers nucleic acid and real-time PCR kits, as well as consumables. The company was founded in 2005 and is based in Shanghai, China.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2005
• Employees: 275
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688317

Financial Performance

In 2024, Shanghai ZJ Bio-Tech's revenue was 178.65 million, a decrease of -34.88% compared to the previous year's 274.33 million. Losses were -127.46 million, -6.86% less than in 2023.